UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Matching-adjusted indirect treatment comparison of liso-cel versus axi-cel in relapsed or refractory large B cell lymphoma

Journal of hematology and oncology, 2021-09, Vol.14 (1), p.1-140, Article 140

2021

Volltextzugriff (PDF)

Rituximab in primary central nervous system lymphoma—A systematic review and meta‐analysis

Hematological oncology, 2019-12, Vol.37 (5), p.548-557

2019

Volltextzugriff (PDF)

Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event

Blood, 2015-12, Vol.126 (25), p.2665-2675

2015

Volltextzugriff (PDF)

Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trial

Blood, 2024-07, Vol.144 (4), p.392-401

2024

Volltextzugriff (PDF)

Idelalisib‐rituximab induces durable remissions in TP53 disrupted B‐PLL but results in significant toxicity: updated results of the UK‐wide compassionate use programme

British journal of haematology, 2019-02, Vol.184 (4), p.667-671

2019

Volltextzugriff (PDF)

Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma

The Lancet. Haematology, 2021-08, Vol.8 (8), p.e542-e544

2021

Volltextzugriff (PDF)

Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

Bone marrow transplantation (Basingstoke), 2019-01, Vol.54 (1), p.44-52

2019

Volltextzugriff (PDF)

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

The Lancet. Haematology, 2017-11, Vol.4 (11), p.e510-e523

2017

Volltextzugriff (PDF)

Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival

British journal of haematology, 2020-08, Vol.190 (3), p.394-404

2020

Volltextzugriff (PDF)

Improved survival outcomes despite older age at diagnosis: an era‐by‐era analysis of patients with primary central nervous system lymphoma treated at a single referral centre in the United Kingdom

British journal of haematology, 2021-11, Vol.195 (4), p.561-570

2021

Volltextzugriff (PDF)

MATRix–RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial

The Lancet. Haematology, 2021-02, Vol.8 (2), p.e110-e121

2021

Volltextzugriff (PDF)

High-dose therapy and autologous stem cell transplantation for extra-nodal NK/T lymphoma in patients from the Western hemisphere: a study from the European Society for Blood and Marrow Transplantation

Leukemia & lymphoma, 2015-12, Vol.56 (12), p.3295-3300

2015

Volltextzugriff (PDF)

Epstein-Barr Virus and Infectious Mononucleosis: What Students Can Teach Us

The Journal of infectious diseases, 2013-01, Vol.207 (1), p.6-8

2013

Volltextzugriff (PDF)

A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs

EJD. European journal of dermatology, 2017-05, Vol.27 (3), p.286-294

2017

Volltextzugriff (PDF)

Impact of Pretransplantation (18)F-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin Lymphoma

Biology of blood and marrow transplantation, 2016-07, Vol.22 (7), p.1234-1241

2016

Volltextzugriff (PDF)

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial

The Lancet. Haematology, 2016-05, Vol.3 (5), p.e217-e227

2016

Volltextzugriff (PDF)

Early versus Delayed Invasive Intervention in Acute Coronary Syndromes

The New England journal of medicine, 2009-05, Vol.360 (21), p.2165-2175

2009

Volltextzugriff (PDF)

Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review

PLoS medicine, 2007-10, Vol.4 (10), p.e298

2007

Volltextzugriff (PDF)

Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation

Proceedings of the National Academy of Sciences - PNAS, 2012-03, Vol.109 (12), p.4598-4603

2012

Volltextzugriff (PDF)

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

The New England journal of medicine, 2020-05, Vol.382 (20), p.1883-1893

2020

Volltextzugriff (PDF)

Metabolite profiles and the risk of developing diabetes

Nature medicine, 2011-04, Vol.17 (4), p.448-453

2011

Volltextzugriff (PDF)

Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial

Journal of the American College of Cardiology, 2013-05, Vol.61 (19), p.1998-2006

2013

Volltextzugriff (PDF)

1 – 25 von 262

Suche als RSS-Feed

Aktive Filter

ThemaAged, 80 And Over

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(255)
Mit Volltextzugriff
(218)

Publikationsform

Artikel
(262)

Sprache

Englisch
(262)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Matching-adjusted indirect treatment comparison of liso-cel versus axi-cel in relapsed or refractory large B cell lymphoma

Rituximab in primary central nervous system lymphoma—A systematic review and meta‐analysis

Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event

Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial

Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trial

Idelalisib‐rituximab induces durable remissions in TP53 disrupted B‐PLL but results in significant toxicity: updated results of the UK‐wide compassionate use programme

Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma

Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival

Improved survival outcomes despite older age at diagnosis: an era‐by‐era analysis of patients with primary central nervous system lymphoma treated at a single referral centre in the United Kingdom

MATRix–RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial

High-dose therapy and autologous stem cell transplantation for extra-nodal NK/T lymphoma in patients from the Western hemisphere: a study from the European Society for Blood and Marrow Transplantation

Epstein-Barr Virus and Infectious Mononucleosis: What Students Can Teach Us

A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs

Impact of Pretransplantation (18)F-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin Lymphoma

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial

Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex

Early versus Delayed Invasive Intervention in Acute Coronary Syndromes

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial

Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review

Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

Metabolite profiles and the risk of developing diabetes

Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial

Aktive Filter

Suchergebnisse filtern